Azenta (AZTA) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting …

BURLINGTON, Mass., Nov. 17, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 9th Annual Evercore Healthcare Conference on Monday, November 30, 2026, which i…

New York, New York--(Newsfile Corp. - November 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: A…

NEW YORK, Nov. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting …

New York, New York--(Newsfile Corp. - November 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: A…

Azenta (NASDAQ: AZTA) forecast faster organic revenue growth and higher profitability for fiscal 2027 after fourth-quarter sales exceeded expectations, as the company works to improve its automated storage business and e…

Allspring Global Investments Holdings LLC reduced its holdings in Azenta, Inc. (NASDAQ: AZTA) by 50.8% during a recent quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…

New York, New York--(Newsfile Corp. - November 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: A…

Wednesday was an ideal day to be invested in Azenta's (AZTA +20.80%) stock. Investors fell over themselves buying shares of the healthcare tech company, and when the scramble subsided, the stock had gained almost 21%.…

Azenta, Inc. ( AZTA ) Q4 2026 Earnings Call November 11, 2026 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations Martin Madaus - Interim President, CEO…

Insider buying and share buybacks have put Prothena, Rapport Therapeutics and Azenta on the radar. See the catalysts and risks behind each stock.…

Q4'26 reported revenue growth of 5% year over year and 2% on an organic basis FY'26 reported revenue growth of 5% year over year and 2% on an organic basis FY'27 reported revenue expected to range from $648 to $660 milli…

New York, New York--(Newsfile Corp. - November 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: A…

Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTAPR NewswireNEW YORK, Nov. 8, 2026NEW YORK, Nov. 8,…

New York, New York--(Newsfile Corp. - November 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZ…

New York, New York--(Newsfile Corp. - November 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZ…

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting …

Azenta (NASDAQ: AZTA - Get Free Report) and Champions Oncology (NASDAQ: CSBR - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on th…

New York, New York--(Newsfile Corp. - November 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZ…

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from …

Azenta is undervalued, with 30% of its market cap in cash and a strong recurring revenue base overlooked due to capital equipment struggles. Recurring streams now exceed 50% of revenue, and the annuity-like custody and c…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 5. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

